High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation

High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation

PurposeModern literature has demonstrated improvements in long-term biochemical outcomes with the use of prophylactic pelvic nodal irradiation followed by a brachytherapy boost in the management of high-risk prostate cancer. However, this comes at the cost of increased treatment-related toxicity. In...

Full description

Bibliographic Details
Main Authors: Jonathan W. Lischalk, Meredith Akerman, Michael C. Repka, Astrid Sanchez, Christopher Mendez, Vianca F. Santos, Todd Carpenter, David Wise, Anthony Corcoran, Herbert Lepor, Aaron Katz, Jonathan A. Haas
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Oncology
Subjects:
prostate
stereotactic body radiation therapy
high-risk
pelvic nodes
boost
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1325200/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1325200/full

Similar Items